Independent Consultant, Inventor of Illumina NGS technology

Dr. Harold Swerdlow

Dr. Harold Swerdlow is currently a freelance consultant. He was previously Senior Director of NGS R&D at DNA Electronics (DNAe) in London.

His role there involved managing Next Generation Sequencing (NGS) technology and product development. Dr. Swerdlow is a leading expert in NGS and recently served as a consultant for ONI (Oxford Nanoimaging, a super-resolution microscopy company), Nuclera Nucleics (a DNA synthesis start-up) and LGC Genomics. He was VP of Sequencing at the New York Genome Center (NYGC) from 2014-17, Head of Research and Development for the Wellcome Trust Sanger Institute in Cambridge, UK (2008-2014) and Chief Technology Officer for Dolomite Ltd. (microfluidics and microfabrication). Prior to Dolomite, from 2000-2006, Dr. Swerdlow was Senior Director of Research at Solexa Ltd., and a key inventor of their innovative NGS technology. Subsequently acquired by Illumina, Solexa’s technology became the core of Illumina’s world-leading NGS products.

Dr. Harold Swerdlow - Independent Consultant, Inventor of Illumina NGS technology

Brings to the SAB expertise in – Next Generation Sequencing, genomics, operational management and system integration.

Discover how ANGLE can help with your liquid biopsy needs